Human isotope fractional absorption studies comparing chelated Magnesium Glycinate vs. Citrate vs. 4% Oxide, CYP2R1/CYP27B1 magnesium-dependent Vitamin D3 activation trials, and Metformin-induced Vitamin B12 holotranscobalamin depletion. Explore 4,328 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
Compared with glimepiride, liraglutide treatment led to greater changes in the circulating metabolome, particularly regarding lipid metabolism involving sphingolipids, including ceramides.
Sertraline single-drug treatment was not superior to placebo for MDD in people with post-acute complicated mild to severe TBI.
The addition of empagliflozin, pioglitazone, or glimepiride to metformin and DPP-4 inhibitors significantly improved glycaemic control in patients with T2D.
In T2D people without CKD, the favourable kidney blood flow and heart rate effects of empagliflozin persist in the postprandial state and are irrespective of concurrent use of linagliptin.
The safety profile was generally consistent with previous studies of RZB in psoriasis.
UP and inflammation were reduced in patients with active RA in Japan in both SAR single-drug treatment and SAR + csDMARDs treatment groups.
Among patients achieving complete response, the estimated 1-year rate of continued response was 68% (95% CI, 45-83).
The use of combined intraocular and sub-Tenons capsule TA is not recommended as an add-on booster to vitrectomy surgery following OGT.
Daridorexant reduced the number and duration of longer wake bouts throughout the night compared with placebo, corresponding with improved daytime functioning.
We have demonstrated the stability of slow-wave and spindle frequency electroencephalograms during non-rapid eye movement sleep within patients with obstructive sleep apnea.
128 ± 62 PRU, NS), with PRU>235 occurring in 3 patients.
Circulating EVs are elevated in individuals with T2D even in the absence of overt vascular complications, suggesting early endothelial activation.
Conclusion: PSMA-targeted PET/MRI-guided biopsy is a reliable, less invasive method for detecting and characterizing PCa in a cohort with moderately increased PSA values, potentially reducing unnecessary biopsies and provides...
Fenofibrate may represent a promising add-on therapy in patients with mild-to-moderate UC by modulating inflammation and improving QoL.
Protocols R or IR proved to be inferior to the R + IR laser photobiomodulation protocol.
Our findings suggest that, in patients with rate-controlled AF, digoxin positively modulates LAS when compared with bisoprolol.
In this phase 3 trial, the overall incidence of grade ≥ 2 rectal toxicity was low and was not significantly different between the 2 arms.
Adding celecoxib to escitalopram may improve symptoms of depression in patients with depression without increasing the risk of drug-related side effects.
Faricimab up to Q16W offered durable vision gains and anatomic improvements up to 2 years in patients with DME in the YOSEMITE Japan subgroup.
This study demonstrated that a newly developed FDCP containing amlodipine, losartan, ezetimibe, and rosuvastatin exhibited how the body absorbs the medicine equivalence with the individual products and met the regulatory criteria.
Escitalopram and sertraline showed comparable efficacy for anxiety symptoms, cognitive function, and daily living abilities in PSD patients.
We found that AGA has a relationship with hyperuricemia, and the level of serum UA can decrease with the treatment of finasteride.
Compared with oral escitalopram alone, repeated transcranial magnetic stimulation in the treatment of middle-aged and older adults patients with depression can further improve the efficacy, and can more effectively improve the...
Prompt diagnosis of AS and early treatment with IV golimumab may yield more robust improvements in disease activity.
EDRT results in improved LC with good functional outcomes without a significant increase in toxic effects.
Electroacupuncture can improve sleep quality and cognitive function in aged trouble sleeping patients, and its mechanism may be related to regulating serum MT and DA levels.
Physiological oral micronized progesterone did not stimulate nor suppress serum sclerostin levels based on post hoc analysis of RCT data.
Six-month treatment with liraglutide improves arterial stiffness, LV myocardial strain, LV twisting and untwisting and NT-proBNP by reducing oxidative stress in subjects with newly diagnosed T2DM.
Preliminary results suggest that the investigation of PRP for the treatment of AGA is promising.
A possible reduction in the incidence of moderate or severe OHSS with the MPA protocol should be viewed with caution as the data is small.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
